$UTHR
UNITED THERAPEUTICS Corp

2013 Q2 Form 10-Q Financial Statement

#000110465913056414 Filed on July 25, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q4 2012 Q2
Revenue $280.6M $243.8M $225.6M
YoY Change 24.39% 24.92% 22.76%
Cost Of Revenue $32.32M $37.70M $29.63M
YoY Change 9.07% 49.01% 39.78%
Gross Profit $245.2M $202.8M $192.2M
YoY Change 27.56% 19.99% 18.36%
Gross Profit Margin 87.37% 83.16% 85.2%
Selling, General & Admin $71.40M $40.10M $53.26M
YoY Change 34.06% -30.5% 122.84%
% of Gross Profit 29.12% 19.78% 27.71%
Research & Development $54.60M $37.50M $37.10M
YoY Change 47.17% -22.84% 53.3%
% of Gross Profit 22.27% 18.49% 19.3%
Depreciation & Amortization $7.600M $7.200M $6.300M
YoY Change 20.63% 46.94% 31.25%
% of Gross Profit 3.1% 3.55% 3.28%
Operating Expenses $126.0M $77.50M $90.36M
YoY Change 39.45% -27.16% 87.85%
Operating Profit $122.3M $125.3M $105.6M
YoY Change 15.83% 100.16% -7.61%
Interest Expense $4.520M -$3.800M $3.879M
YoY Change 16.52% -7.32% -184.33%
% of Operating Profit 3.7% -3.03% 3.67%
Other Income/Expense, Net -$3.785M $100.0K -$2.297M
YoY Change 64.78% -83.33% 665.67%
Pretax Income $118.5M $125.0M $103.3M
YoY Change 14.74% 108.33% -5.76%
Income Tax $38.70M $41.70M $30.97M
% Of Pretax Income 32.65% 33.36% 29.99%
Net Earnings $79.90M $83.30M $72.30M
YoY Change 10.51% 92.82% 6.32%
Net Earnings / Revenue 28.47% 34.16% 32.05%
Basic Earnings Per Share $1.60 $1.65 $1.37
Diluted Earnings Per Share $1.52 $1.60 $1.34
COMMON SHARES
Basic Shares Outstanding 49.80M shares 50.80M shares 52.75M shares
Diluted Shares Outstanding 52.65M shares 53.94M shares

Balance Sheet

Concept 2013 Q2 2012 Q4 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $696.6M $479.2M $392.4M
YoY Change 77.52% 18.76% -46.26%
Cash & Equivalents $343.6M $154.0M $157.0M
Short-Term Investments $353.0M $325.2M $235.4M
Other Short-Term Assets $30.70M $35.39M $33.00M
YoY Change -6.97% 471.83% 40.43%
Inventory $44.71M $37.25M $46.63M
Prepaid Expenses $17.05M
Receivables $131.6M $116.6M $98.60M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $903.6M $668.5M $570.6M
YoY Change 58.36% 18.85% -34.97%
LONG-TERM ASSETS
Property, Plant & Equipment $447.9M $453.7M $435.8M
YoY Change 2.78% 23.94% 38.39%
Goodwill $10.47M $10.53M
YoY Change 29.63%
Intangibles
YoY Change
Long-Term Investments $198.1M $305.7M $308.9M
YoY Change -35.87% -11.11% 96.5%
Other Assets $213.2M $26.78M $224.0M
YoY Change -4.82% -3.4% 2.14%
Total Long-Term Assets $874.1M $958.1M $985.8M
YoY Change -11.33% 0.26% 40.59%
TOTAL ASSETS
Total Short-Term Assets $903.6M $668.5M $570.6M
Total Long-Term Assets $874.1M $958.1M $985.8M
Total Assets $1.778B $1.627B $1.556B
YoY Change 14.22% 7.15% -1.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.400M $10.20M $8.700M
YoY Change 8.05% -78.41% -49.12%
Accrued Expenses $81.70M $72.99M $67.20M
YoY Change 21.58% 27.54% 8.39%
Deferred Revenue
YoY Change
Short-Term Debt $210.2M $1.300M $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $412.2M $176.8M $187.7M
YoY Change 119.66% -16.85% -58.62%
LONG-TERM LIABILITIES
Long-Term Debt $70.30M $275.0M $270.8M
YoY Change -74.04% 3.54% 293.03%
Other Long-Term Liabilities $79.00M $79.97M $77.50M
YoY Change 1.94% -0.66% 80.23%
Total Long-Term Liabilities $149.3M $79.97M $348.3M
YoY Change -57.13% -0.66% 211.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $412.2M $176.8M $187.7M
Total Long-Term Liabilities $149.3M $79.97M $348.3M
Total Liabilities $561.5M $531.7M $535.9M
YoY Change 4.78% -4.83% -5.23%
SHAREHOLDERS EQUITY
Retained Earnings $553.5M
YoY Change 122.25%
Common Stock $1.016B
YoY Change 2.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $471.0M
YoY Change 66.43%
Treasury Stock Shares 12.63M shares 11.92M shares
Shareholders Equity $1.216B $1.084B $1.010B
YoY Change
Total Liabilities & Shareholders Equity $1.778B $1.627B $1.556B
YoY Change 14.22% 7.15% -1.41%

Cashflow Statement

Concept 2013 Q2 2012 Q4 2012 Q2
OPERATING ACTIVITIES
Net Income $79.90M $83.30M $72.30M
YoY Change 10.51% 92.82% 6.32%
Depreciation, Depletion And Amortization $7.600M $7.200M $6.300M
YoY Change 20.63% 46.94% 31.25%
Cash From Operating Activities $83.80M $105.2M $87.40M
YoY Change -4.12% 103.88% 35.5%
INVESTING ACTIVITIES
Capital Expenditures -$4.900M -$21.20M -$43.60M
YoY Change -88.76% -3128.57% 246.03%
Acquisitions
YoY Change
Other Investing Activities $31.40M -$143.5M $43.30M
YoY Change -27.48% -1031.82% -236.59%
Cash From Investing Activities $26.60M -$164.7M -$300.0K
YoY Change -8966.67% -1116.67% -99.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.10M -49.90M -86.30M
YoY Change -66.28% -79.92% -819.17%
NET CHANGE
Cash From Operating Activities 83.80M 105.2M 87.40M
Cash From Investing Activities 26.60M -164.7M -300.0K
Cash From Financing Activities -29.10M -49.90M -86.30M
Net Change In Cash 81.30M -109.4M 800.0K
YoY Change 10062.5% -39.46% -97.52%
FREE CASH FLOW
Cash From Operating Activities $83.80M $105.2M $87.40M
Capital Expenditures -$4.900M -$21.20M -$43.60M
Free Cash Flow $88.70M $126.4M $131.0M
YoY Change -32.29% 148.33% 69.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
uthr Commercial Products Number
CommercialProductsNumber
3 item
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
18376000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.69
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2013Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
353041000 USD
CY2012Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
325175000 USD
CY2013Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
197684000 USD
CY2012Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
305253000 USD
CY2013Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
154864000 USD
CY2012Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
163687000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13603000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11881000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11708000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14456000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11943000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
44713000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
37254000 USD
CY2013Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
550725000 USD
CY2013Q2 us-gaap Heldtomaturity Securities Unrecognized Holding Gain
HeldtomaturitySecuritiesUnrecognizedHoldingGain
266000 USD
CY2013Q2 us-gaap Held To Maturity Securities Unrecognized Holding Loss
HeldToMaturitySecuritiesUnrecognizedHoldingLoss
129000 USD
CY2013Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
550862000 USD
CY2012Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
630428000 USD
CY2012Q4 us-gaap Heldtomaturity Securities Unrecognized Holding Gain
HeldtomaturitySecuritiesUnrecognizedHoldingGain
445000 USD
CY2012Q4 us-gaap Held To Maturity Securities Unrecognized Holding Loss
HeldToMaturitySecuritiesUnrecognizedHoldingLoss
175000 USD
CY2012Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
630698000 USD
CY2013Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Aggregate Losses
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAggregateLosses
129000 USD
CY2012Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Aggregate Losses
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAggregateLosses
175000 USD
CY2013Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
353041000 USD
CY2013Q2 uthr Held To Maturity Securities Debt Maturities In One Year Through Two Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesInOneYearThroughTwoYearsNetCarryingAmount
197684000 USD
CY2013Q2 us-gaap Held To Maturity Securities Debt Maturities Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount
550725000 USD
CY2013Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
353212000 USD
CY2013Q2 uthr Held To Maturity Securities Debt Maturities In One Year Through Two Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesInOneYearThroughTwoYearsFairValue
197650000 USD
CY2013Q2 us-gaap Held To Maturity Securities Debt Maturities Fair Value
HeldToMaturitySecuritiesDebtMaturitiesFairValue
550862000 USD
CY2013Q2 uthr Available For Sale Securities Equity Securities Investment Percentage Less Than
AvailableForSaleSecuritiesEquitySecuritiesInvestmentPercentageLessThan
0.01 pure
CY2013Q2 us-gaap Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
38800000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1311000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1030000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
531000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
354000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3226000 USD
CY2013Q2 us-gaap Goodwill Gross
GoodwillGross
10465000 USD
CY2012Q4 us-gaap Goodwill Gross
GoodwillGross
10530000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
10465000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
10530000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7010000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5750000 USD
CY2013Q2 uthr Goodwill And Other Intangibles Assets Gross
GoodwillAndOtherIntangiblesAssetsGross
21949000 USD
CY2012Q4 uthr Goodwill And Other Intangibles Assets Gross
GoodwillAndOtherIntangiblesAssetsGross
22158000 USD
CY2013Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
14939000 USD
CY2012Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
16408000 USD
CY2013Q2 uthr Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
207000 USD
uthr Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
414000 USD
CY2013Q2 uthr Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
199000 USD
uthr Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
397000 USD
CY2013Q2 uthr Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
406000 USD
uthr Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
811000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-134000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-270000 USD
CY2013Q2 uthr Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
272000 USD
uthr Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
541000 USD
CY2013Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
4520000 USD
CY2012Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
4361000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
8956000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
8670000 USD
CY2012Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
482000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
905000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
4520000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
3879000 USD
us-gaap Interest Expense
InterestExpense
8956000 USD
us-gaap Interest Expense
InterestExpense
7765000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
79864000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
72316000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
142189000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
143076000 USD
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52747000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50003000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53189000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1362000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1120000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1486000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1263000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1195000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1227000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52648000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53942000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52386000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54416000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.63
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10485000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11761000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11026000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11761000 shares
CY2013Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
205323 shares
CY2012Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67199 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
354690 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
140114 shares
CY2013Q2 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
5838000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
1304000 USD
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
10097000 USD
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
3114000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
420000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P1Y
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
708998 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
42400000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14957000 USD
uthr Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-2670000 USD
uthr Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-512000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2158000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17115000 USD
uthr Estimated Annual Effective Income Tax Rate
EstimatedAnnualEffectiveIncomeTaxRate
0.33 pure
uthr Estimated Annual Effective Income Tax Rate
EstimatedAnnualEffectiveIncomeTaxRate
0.32 pure
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
277495000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
32320000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
245175000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
221832000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
29633000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
192199000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
520641000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
61633000 USD
us-gaap Gross Profit
GrossProfit
459008000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
424775000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
53664000 USD
us-gaap Gross Profit
GrossProfit
371111000 USD
CY2013Q2 uthr Entity Wide Revenue Major Us Based Distributors Number
EntityWideRevenueMajorUSBasedDistributorsNumber
3 item
CY2012Q2 uthr Entity Wide Revenue Major Us Based Distributors Number
EntityWideRevenueMajorUSBasedDistributorsNumber
3 item
uthr Entity Wide Revenue Major Us Based Distributors Number
EntityWideRevenueMajorUSBasedDistributorsNumber
3 item
uthr Entity Wide Revenue Major Us Based Distributors Number
EntityWideRevenueMajorUSBasedDistributorsNumber
3 item
CY2013Q2 uthr Entity Wide Revenue Major Us Based Distributors Percentage
EntityWideRevenueMajorUSBasedDistributorsPercentage
0.77 pure
CY2012Q2 uthr Entity Wide Revenue Major Us Based Distributors Percentage
EntityWideRevenueMajorUSBasedDistributorsPercentage
0.78 pure
uthr Entity Wide Revenue Major Us Based Distributors Percentage
EntityWideRevenueMajorUSBasedDistributorsPercentage
0.77 pure
CY2013Q2 us-gaap Assets Current
AssetsCurrent
903583000 USD
uthr Entity Wide Revenue Major Us Based Distributors Percentage
EntityWideRevenueMajorUSBasedDistributorsPercentage
0.80 pure
dei Entity Registrant Name
EntityRegistrantName
UNITED THERAPEUTICS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001082554
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49923520 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1. Organization and Business Description</font></b></p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#160;</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. As used in these notes to the consolidated financial statements, unless the context otherwise requires, the terms &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our,&#8221; and similar terms refer to United Therapeutics Corporation and its consolidated subsidiaries.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#160;</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">We have three commercial products approved by the United States Food and Drug Administration (FDA): Remodulin</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;(treprostinil) Injection (Remodulin), Tyvaso</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;(treprostinil) Inhalation Solution (Tyvaso) and Adcirca</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;(tadalafil) tablets (Adcirca). Remodulin has also been approved in various other countries.</font></p> </div>
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">2. Basis of Presentation</font></b></p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#160;</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The accompanying unaudited consolidated financial statements have been prepared in accordance with the rules&#160;and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information. Accordingly, they do not include all of the information required by United States generally accepted accounting principles (GAAP) for complete financial statements. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the accompanying notes to the consolidated financial statements contained in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2012, as filed with the SEC on February&#160;26, 2013.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#160;</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In our management&#8217;s opinion, the accompanying consolidated financial statements contain all adjustments, including normal, recurring adjustments, necessary to fairly present our financial position as of June&#160;30, 2013, results of operations and comprehensive income for the three- and six-month periods ended June&#160;30, 2013 and 2012, and cash flows for the six-month periods ended June&#160;30, 2013 and 2012. Interim results are not necessarily indicative of results for an entire year.</font></p> </div>
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
305726000 USD
CY2012Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
5377000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453685000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
150147000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26782000 USD
CY2012Q4 us-gaap Assets
Assets
1626595000 USD
CY2013Q2 us-gaap Assets
Assets
1777673000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72985000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10203000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
176755000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
412225000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
621000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154030000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
116626000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3778000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17053000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
14554000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
668470000 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
204667000 USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
70343000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79967000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
531732000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Liabilities
Liabilities
561534000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1015835000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
470998000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
553480000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1083981000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1626595000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1777673000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
12625052 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11916054 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62465829 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49840777 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62082007 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50165953 shares
CY2012Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
3745000 USD
CY2012Q2 us-gaap Revenues
Revenues
225577000 USD
us-gaap Revenues
Revenues
525742000 USD
CY2013Q2 us-gaap Revenues
Revenues
280606000 USD
us-gaap Revenues
Revenues
429791000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
5016000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37099000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53258000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70756000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93047000 USD
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
119990000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
158302000 USD
us-gaap Costs And Expenses
CostsAndExpenses
309401000 USD
us-gaap Costs And Expenses
CostsAndExpenses
217467000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
30766000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
105587000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
212324000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
122304000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
216341000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1055000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2087000 USD
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-42000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-62000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
569000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
642000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2297000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5098000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3785000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6987000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
103290000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
209354000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
207226000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
118519000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30974000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64150000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1487000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-388000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
64000 USD
CY2012Q2 uthr Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
130000 USD
uthr Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
261000 USD
CY2012Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-130000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-325000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-15000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
143049000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
70944000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
140031000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79712000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-152000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1372000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12940000 USD
uthr Provision For Doubtful Accounts And Inventory Writedown
ProvisionForDoubtfulAccountsAndInventoryWritedown
1690000 USD
uthr Income Tax Cash Flows
IncomeTaxCashFlows
64150000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9423000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5905000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2333000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8213000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
684000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
181546000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
124971000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-72009000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9544000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38549000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1590000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9215000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1468000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8788000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83920000 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
291417000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
329059000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-46278000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
37204000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
88000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3114000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
684000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-84202000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-28389000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-154000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5663000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
189520000 USD
us-gaap Interest Paid Net
InterestPaidNet
2558000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
56309000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5904000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157013000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162676000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343550000 USD
CY2013Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
210166000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
93567000 USD

Files In Submission

Name View Source Status
0001104659-13-056414-index-headers.html Edgar Link pending
0001104659-13-056414-index.html Edgar Link pending
0001104659-13-056414.txt Edgar Link pending
0001104659-13-056414-xbrl.zip Edgar Link pending
a13-13749_110q.htm Edgar Link pending
a13-13749_1ex31d1.htm Edgar Link pending
a13-13749_1ex31d2.htm Edgar Link pending
a13-13749_1ex32d1.htm Edgar Link pending
a13-13749_1ex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
uthr-20130630.xml Edgar Link completed
uthr-20130630.xsd Edgar Link pending
uthr-20130630_cal.xml Edgar Link unprocessable
uthr-20130630_def.xml Edgar Link unprocessable
uthr-20130630_lab.xml Edgar Link unprocessable
uthr-20130630_pre.xml Edgar Link unprocessable